Table 2:
Immediate risk of CN3+ among different interpretation TBS categories.[14]
| Cytologic interpretation | Immediate risk of CIN3+ | |
|---|---|---|
| HR-HPV (–) | HR-HPV (+) | |
| NILM | 0.00 | 2.1 |
| ASC-US | 0.04 | 4.4 |
| LSIL | 1.1 | 4.3 |
| ASC-H | 3.4 | 25 |
| HSIL | 25 | 48 |
The patient management for abnormal PAP relies on the immediate risk of CIN3+. Adopted from the (2019) ASCCP management consensus guidelines. Egemen D et al. “Risk estimates supporting the 2019 ASCCP risk-based management consensus guidelines.” Journal of lower genital tract disease 24.2 (2020): 132